Published by Josh White on 25th October 2018
(Sharecast News) - Liquid biopsy company Angle announced on Thursday that patient enrolment for its ANG-002 FDA clinical study for metastatic breast cancer had continued to make good progress.
URL: http://www.digitallook.com/dl/news/story/28185985/...